Angiogenin contributes to bladder cancer tumorigenesis by DNMT3b-mediated MMP2 activation

Rafael Peres1, Hideki Furuya1, Ian Pagano2

  • 1University of Hawaii Cancer Center, Clinical & Translational Research Program, Honolulu, HI, USA.

Oncotarget
|June 19, 2016
PubMed

Insights

Angiogenin (ANG) activates matrix metalloproteinase-2 (MMP2) by altering DNA methylation, promoting human tumorigenesis. This mechanism involves downregulating DNA methyltransferase 3b (DNMT3b), impacting cancer patient survival.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Epigenetics

Background:

  • Epigenetic gene regulation is critical in human cancer development.
  • Previous research identified an interplay between Angiogenin (ANG) and matrix metalloproteinase-2 (MMP2) in tumorigenesis.

Purpose of the Study:

  • To elucidate the oncogenic potential of ANG and its mechanism in human cancer.
  • To investigate the role of ANG in regulating MMP2 expression and its epigenetic modifications.

Main Methods:

  • DNA methylation microarray analysis.
  • Gene expression analysis of ANG, MMP2, and DNMT3b.
  • Assessment of DNMT3b activity and promoter recruitment.

Main Results:

  • ANG expression led to hypomethylation and increased expression of the MMP2 gene.
  • ANG manipulation affected cell migration, angiogenesis, and tumor suppressor gene pathways.
  • ANG negatively regulated DNMT3b expression and activity, inhibiting its binding to the MMP2 promoter.
  • ANG overexpression and MMP2 overexpression, along with DNMT3b underexpression, correlated with reduced disease-free survival in bladder cancer patients.

Conclusions:

  • ANG functions as an oncoprotein by activating MMP2 through epigenetic mechanisms.
  • ANG contributes to oncogenesis by modulating DNMT3b activity, leading to MMP2 activation.
  • The ANG-MMP2 pathway and DNMT3b levels serve as potential prognostic markers for human bladder cancer.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.8K